Analyst stock forecast
Mereo BioPharma Group Forecast: $2.01 Analyst Target
MREO has a $2.01 target, Buy rating and 5 analysts. As of 2026-08-25.
Direct answer
Mereo BioPharma Group's average price target is $2.01.
The target implies +595.9% from the recorded current price, and the consensus rating is Buy.
The low target implies +248.5%, the high target implies +946%, and the range spans 697.5% of the current price.
Forecast evidence checked August 25, 2026.
Get free Mereo BioPharma Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.29
- Average price target
- $2.01
- High price target
- $3.03
- Low price target
- $1.01
- Low target gap
- +248.5%
- Target upside
- +595.9%
- High target gap
- +946%
- Target range width
- 697.5%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- August 25, 2026
- Valid through
- September 1, 2026
Explore related company data
Read the frequently asked questions.
What is Mereo BioPharma Group's average price target?
Mereo BioPharma Group's verified average price target is $2.01. The target range is $1.01 to $3.03.
How far are Mereo BioPharma Group's low and high targets from the recorded price?
The low target implies +248.5%, while the high target implies +946%.
How many analysts are included in Mereo BioPharma Group's consensus?
The verified consensus includes 5 analysts.
How is Mereo BioPharma Group's target upside or downside calculated?
The average target of $2.01 is divided by the recorded price of $0.29, then one is subtracted to produce +595.9%. This does not guarantee a future return.
When was Mereo BioPharma Group's analyst forecast verified?
The data was verified on 2026-08-25. The dataset is valid through 2026-09-01.